Allakos Receives $17,949,545 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b18f0571-ec7c-4ce0-afbb-aab4789566c5 - Date
3/26/2015 - Company Name
Allakos - Mailing Address
75 Shoreway Road San Carlos, CA 94070 USA - Company Description
Allakos Inc. is a privately held, product-focused biotechnology company developing first-in-class antibody-based therapeutics to treat diseases in which dysregulation of the T-helper type 2 (Th2) immune response plays a key role in pathology, including allergic disease, inflammation and diseases characterized by excess production of inflammatory cells. - Website
http://www.allakos.com - Transaction Type
Venture Equity - Transaction Amount
$17,949,545 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
